Biomerica Inc
Research Biomerica Inc (BMRA) on Bullrun: market cap USD 5.88M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBMRA
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 5.88M
- Financial periodFY2026
- RevenueUSD 4.45M
- Revenue growth-16.2%
- Net income-USD 3.78M
- Free cash flow-USD 3.42M
- Gross margin8.1%
Valuation Snapshot
latest market cap is USD 5.88M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 4.45M | -USD 3.78M | -USD 3.42M | 8.1% | n/a | USD 1.31M | USD 2.38M | USD 2.63M |
| FY2025 | USD 5.31M | -USD 4.97M | -USD 3.88M | 9.4% | -2.16 | USD 3.06M | USD 458.00K | USD 4.11M |
| FY2024 | USD 5.42M | -USD 5.98M | -USD 5.41M | 11.3% | -2.84 | USD 4.17M | USD 785.00K | USD 6.59M |
| FY2023 | USD 5.34M | -USD 7.14M | -USD 5.54M | 8.4% | -0.5 | USD 9.72M | USD 1.08M | USD 11.72M |
| FY2022 | USD 18.87M | -USD 4.53M | -USD 536.00K | 15.8% | -0.36 | USD 5.92M | USD 1.38M | USD 8.33M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 5.88M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 7.43M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 5.50M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 21.03M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 45.16M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 49.37M | n/a | n/a | n/a |
About Biomerica Inc
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing of diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases in North America, Asia, Europe, the Middle East, and South America.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Biomerica Inc's market cap?
Biomerica Inc's market capitalization is USD 5.88M.
What does Biomerica Inc do?
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing of diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases in North America, Asia, Europe, the Middle East, and South America.